Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges

3. Key Analytics
3.1. Porter’S Five Forces Analysis
3.1.1. Threat Of New Entry
3.1.2. Threat Of Substitution
3.1.3. Buyer’S Power
3.1.4. Supplier’S Power
3.1.5. Competitive Rivalry
3.2. Impact Of Covid-19 On Anticoagulants Market
3.3. Opportunity Matrix
3.4. Vendor Landscape
3.5. Key Investment Insights

4. Market By Application
4.1. Atrial Fibrillation & Heart Attack
4.2. Pulmonary Embolism (Pe)
4.3. Deep Vein Thrombosis (Dvt)
4.4. Stroke
4.5. Other Applications

5. Market By Route Of Administration
5.1. Oral Anticoagulants
5.2. Injectable Anticoagulants

6. Market By Drug Class
6.1. Noacs
6.2. Heparins & Low-Molecular-Weight Heparins (Lmwhs)
6.3. Vitamin K Antagonists
6.4. Other Drug Class

7. Competitive Landscape
7.1. Key Strategic Developments
7.1.1. Merger & Acquisitions
7.1.2. Product Launch & Developments
7.1.3. Partnership, Contract/Agreement & Collaboration
7.1.4. Business Expansion/ Approval/ Announcement
7.2. Company Profile
7.2.1. Abbott Laboratories
7.2.2. Daiichi Sankyo
7.2.3. Dr. Reddy’S Laboratories
7.2.4. Johnson & Johnson
7.2.5. Pfizer Inc



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: India Anticoagulants Market, By Application, In 2020
Figure 6: India Anticoagulants Market, By Atrial Fibrillation & Heart Attack, 2021-2025 (In $ Million)
Figure 7: India Anticoagulants Market, By Pulmonary Embolism (Pe), 2021-2025 (In $ Million)
Figure 8: India Anticoagulants Market, By Deep Vein Thrombosis (Dvt), 2021-2025 (In $ Million)
Figure 9: India Anticoagulants Market, By Stroke, 2021-2025 (In $ Million)
Figure 10: India Anticoagulants Market, By Other Applications, 2021-2025 (In $ Million)
Figure 11: India Anticoagulants Market, By Route Of Administration, In 2020
Figure 12: India Anticoagulants Market, By Oral Anticoagulants, 2021-2025 (In $ Million)
Figure 13: India Anticoagulants Market, By Injectable Anticoagulants, 2021-2025 (In $ Million)
Figure 14: India Anticoagulants Market, By Drug Class, In 2020
Figure 15: India Anticoagulants Market, By Noacs, 2021-2025 (In $ Million)
Figure 16: India Anticoagulants Market, By Heparins & Low-Molecular-Weight Heparins (Lmwhs), 2021-2025 (In $ Million)
Figure 17: India Anticoagulants Market, By Vitamin K Antagonists, 2021-2025 (In $ Million)
Figure 18: India Anticoagulants Market, By Other Drug Class, 2021-2025 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - ANTICOAGULANTS
TABLE 2: INDIA ANTICOAGULANTS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: INDIA ANTICOAGULANTS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2025 (IN $ MILLION)
TABLE 4: INDIA ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: INDIA ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2025 (IN $ MILLION)
TABLE 6: INDIA ANTICOAGULANTS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: INDIA ANTICOAGULANTS MARKET, BY DRUG CLASS, FORECAST YEARS, 2021-2025 (IN $ MILLION)